Hospital Doce de Octubre

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma2 trials
• Acute lymphoblastic leukaemia1 trial
• Heart failure1 trial

Phase

• Phase 22 trials

Status

• Active, not recruiting2 trials
• Not yet recruiting2 trials

Lead sponsor

• PETHEMA Foundation3 trials
• Boston Scientific Corporation1 trial

Running trials

• Not yet recruiting

  Elranatamab With Mezigdomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

  NCT07901868· Phase 2· PETHEMA Foundation· Source

  Contact: Alfonso Santiago, PhD

• Not yet recruiting

  Treatment for Ph-negative ALL for Adults up to 65 Years

  NCT07443592· PETHEMA Foundation· Source

  Contact: Pilar Martínez, Dr (principal investigator)

• Active, not recruiting

  Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma

  NCT05849610· Phase 2· PETHEMA Foundation· Source

• Active, not recruiting

  Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)

  NCT01385176· Boston Scientific Corporation· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Multiple myeloma1 recruiting